The European Medicines Agency (EMA) has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer ...

EUR/USD shifted lower for a fourth consecutive trading day on Thursday, peaking near 1.0450 before softening to shed ...

Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

Dilafor has completed interactions with US and European authorities during 2023 – 2024 to achieve an alignment in the regulatory process ahead of the upcoming clinical phase 3 trials with the ...

The Pound Sterling exhibits a sharp volatility contraction around 1.2450 against the US Dollar on Thursday. The near-term ...

Japan’s retail sales and job data fuel BoJ rate hike bets, pressuring USD/JPY. Fed’s inflation stance also in focus. Will USD ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

Discover why Johnson & Johnson is a top stock pick for income investors in 2025 with strong sales growth and promising ...

The US dollar is looking at the nonsense at the FOMC press conference from the previous session, as well as a cooler than expected Advanced GDP in the US.